These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8109830)

  • 21. Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft.
    Nardo B; Valdivia LA; Catena F; Cavallari G; Demetris AJ; Rao AS; Fung JJ; Starzl TE; Cavallari A
    Transplant Proc; 2000 Dec; 32(8):2710-2. PubMed ID: 11134771
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM
    Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633
    [No Abstract]   [Full Text] [Related]  

  • 23. Mycophenolate mofetil and brequinar sodium: new immunosuppressive agents.
    Hullett DA; Sollinger HW
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):45-7. PubMed ID: 8516943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of the in vitro and in vivo immunosuppressive activity of brequinar sodium.
    Eiras-Hreha G; Cramer DV; Cajulis E; Cosenza C; Mills L; Hough K; Frankland M; Chapman F; Wang H; Zajac I
    Transplant Proc; 1993 Feb; 25(1 Pt 1):708-9. PubMed ID: 8438448
    [No Abstract]   [Full Text] [Related]  

  • 25. The antilymphocytic activity of brequinar sodium and its potentiation by cytidine. Effects on lymphocyte proliferation and cytokine production.
    Woo J; Lemster B; Tamura K; Starzl TE; Thomson AW
    Transplantation; 1993 Aug; 56(2):374-81. PubMed ID: 8356593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin.
    Valdivia LA; Demetris AJ; Fung JJ; Celli S; Murase N; Starzl TE
    Transplantation; 1993 Mar; 55(3):659-61. PubMed ID: 7681230
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production.
    Hasan R; Van den Bogaerde JB; Wallwork J; White DJ
    Transplantation; 1992 Sep; 54(3):408-13. PubMed ID: 1412718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM; Kahan BD
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of natural antibody synthesis by cyclophosphamide or 15-deoxyspergualin fails to prevent xenograft rejection in the guinea pig-to-rat model.
    Leventhal JR; Platt JL; Flores HC; Gruber SA; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):551. PubMed ID: 1566426
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of AS2541019, a novel selective PI3Kδ inhibitor, on antibody production and hamster to rat xenotransplantation.
    Marui T; Fukahori H; Kawashima T; Ito M; Akamatsu M; Kaneko Y; Takahashi F; Imada S; Morokata T
    Eur J Pharmacol; 2018 May; 826():179-186. PubMed ID: 29518396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase-directed therapy and cardiac xenograft survival.
    Lin H; Gastman BR; Wei RQ; Kunkel SL; Gordon D; Bolling SF
    J Surg Res; 1997 Sep; 72(1):84-8. PubMed ID: 9344718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447
    [No Abstract]   [Full Text] [Related]  

  • 33. Fludarabine phosphate and 2-chlorodeoxyadenosine: immunosuppressive DNA synthesis inhibitors with potential application in islet allo- and xenotransplantation.
    Goodman ER; Fiedor PS; Fein S; Sung RS; Athan E; Hardy MA
    Transplant Proc; 1995 Dec; 27(6):3293-4. PubMed ID: 8539960
    [No Abstract]   [Full Text] [Related]  

  • 34. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel immunosuppressant, IR-1116, which has a different biological mechanism from that of cyclosporine A.
    Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T
    Eur J Immunol; 1993 Sep; 23(9):2121-8. PubMed ID: 8370395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of Brequinar as an immunosuppressive drug for transplantation.
    Makowka L; Sher LS; Cramer DV
    Immunol Rev; 1993 Dec; 136():51-70. PubMed ID: 8132203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolongation of cardiac xenograft survival in rats receiving cyclosporin A.
    Homan WP; Williams KA; Fabre JW; Millard PR; Morris PJ
    Transplantation; 1981 Mar; 31(3):164-6. PubMed ID: 7015610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 15-deoxyspergualin in islet xenograft rejection.
    Yoshimura A; Nakajima Y; Kanehiro H; Nakano H
    Transplant Proc; 1996 Jun; 28(3):1426-7. PubMed ID: 8658724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.